MLICM
NUVA

Metropolitan Life Insurance Company (MetLife)’s NuVasive, Inc. NUVA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,906
Closed -$121K – 2473
2023
Q2 		$121K Hold
2,906
– – 0.01% 920
2023
Q1 		$120K Sell
2,906
-283
-9% -$12.1K 0.01% 912
2022
Q4 		$132K Hold
3,189
– – 0.01% 918
2022
Q3 		$140K Hold
3,189
– – 0.01% 830
2022
Q2 		$157K Hold
3,189
– – 0.01% 824
2022
Q1 		$181K Sell
3,189
-18,802
-85% -$999K 0.01% 865
2021
Q4 		$1.15M Sell
21,991
-180
-0.8% -$9.78K 0.02% 871
2021
Q3 		$1.33M Sell
22,171
-1,548
-7% -$95.4K 0.02% 773
2021
Q2 		$1.61M Buy
23,719
+947
+4% +$64.7K 0.02% 668
2021
Q1 		$1.49M Sell
22,772
-308
-1% -$18.5K 0.02% 693
2020
Q4 		$1.3M Sell
23,080
-210
-0.9% -$10.3K 0.02% 711
2020
Q3 		$1.13M Sell
23,290
-1,387
-6% -$74.7K 0.02% 666
2020
Q2 		$1.37M Sell
24,677
-3,906
-14% -$226K 0.02% 559
2020
Q1 		$1.45M Sell
28,583
-609
-2% -$40.8K 0.03% 508
2019
Q4 		$2.26M Sell
29,192
-954
-3% -$67.4K 0.04% 475
2019
Q3 		$1.91M Buy
30,146
+259
+0.9% +$16.2K 0.03% 524
2019
Q2 		$1.75M Buy
29,887
+69
+0.2% +$4.07K 0.03% 585
2019
Q1 		$1.69M Buy
29,818
+52
+0.2% +$2.76K 0.03% 576
2018
Q4 		$1.48M Buy
29,766
+185
+0.6% +$11.1K 0.03% 590
2018
Q3 		$2.1M Buy
29,581
+16
+0.1% +$1.02K 0.04% 496
2018
Q2 		$1.54M Buy
29,565
+95
+0.3% +$4.98K 0.03% 680
2018
Q1 		$1.54M Buy
29,470
+405
+1% +$20.5K 0.02% 691
2017
Q4 		$1.7M Sell
29,065
-51,519
-64% -$2.92M 0.02% 636
2017
Q3 		$4.47M Sell
80,584
-32
-0% -$2.12K 0.03% 645
2017
Q2 		$6.2M Buy
80,616
+1,608
+2% +$120K 0.04% 447
2017
Q1 		$5.9M Sell
79,008
-1,439
-2% -$104K 0.04% 479
2016
Q4 		$5.42M Sell
80,447
-515
-0.6% -$33.2K 0.04% 516
2016
Q3 		$5.4M Buy
80,962
+45,122
+126% +$2.87M 0.04% 480
2016
Q2 		$2.14M Buy
35,840
+1,476
+4% +$79.8K 0.02% 911
2016
Q1 		$1.67M Buy
34,364
+426
+1% +$19.3K 0.01% 956
2015
Q4 		$1.84M Buy
33,938
+892
+3% +$45.5K 0.01% 920
2015
Q3 		$1.59M Sell
33,046
-289
-0.9% -$14.9K 0.01% 1003
2015
Q2 		$1.58M Sell
33,335
-1,570
-4% -$73.4K 0.01% 1056
2015
Q1 		$1.6M Hold
34,905
– – 0.01% 974
2014
Q4 		$1.65M Sell
34,905
-2,143
-6% -$89.3K 0.01% 1048
2014
Q3 		$1.29M Hold
37,048
– – 0.01% 1129
2014
Q2 		$1.32M Buy
37,048
+1,497
+4% +$51.2K 0.01% 1185
2014
Q1 		$1.37M Hold
35,551
– – 0.01% 1148
2013
Q4 		$1.15M Buy
35,551
+85
+0.2% +$2.55K 0.01% 1244
2013
Q3 		$869K Hold
35,466
– – 0.01% 1365
2013
Q2 		$879K Buy
+35,466
New +$776K 0.01% 1310

Other funds holding NUVA

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s NUVA Position: Q3 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 2,906 shares — an estimated $121K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NUVA in Q2 2013 and held it in 41 quarters. The position peaked at $6.2M in Q2 2017. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,906 NuVasive, Inc. shares in Q3 2023, an estimated $121K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in NuVasive, Inc. in Q2 2013 and held it in 41 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s NuVasive, Inc. position peaked at $6.2M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2023, filed 14 Nov 2023.